Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2021-12-05 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
2021年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2021 first extraordinary general meeting (临时股东大会) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes information about the meeting date, attendance, voting results on various proposals, including election of a director, and legal opinions confirming the validity of the meeting and votes. The document is not a full annual or interim report, nor a financial statement or earnings release. It is not a proxy solicitation or a presentation. It is a formal announcement of voting results from a shareholders meeting. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2755 characters, which is consistent with a detailed voting results announcement rather than a full report.
2021-12-05 Chinese
北京市康达律师事务所关于北京颖泰嘉和生物科技股份有限公司2021年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, and voting procedures of a company's 2021 first extraordinary general meeting (临时股东大会). It details the legality and validity of the meeting's call, attendance, and voting results. The document does not contain financial statements or results but focuses on the procedural and legal aspects of the shareholder meeting. It is not a report of voting results per se but a legal opinion on the meeting's conduct. Given the content and purpose, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to the official confirmation and legal opinion on the shareholder meeting and its voting outcomes.
2021-12-05 Chinese
关于2022年度开展远期结售汇等外汇衍生产品业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the board of directors of Beijing Yingtai Jiahe Biotechnology Co., Ltd. regarding the company's plan to conduct forward foreign exchange settlement and other foreign exchange derivative product businesses in 2022. It includes details about the business purpose, types of products, expected business scale, risk analysis, and risk control measures. The document is a formal announcement of a board resolution approving this business plan. It does not contain financial statements, quarterly or annual results, nor is it a transcript, audit report, or any other detailed financial report. It is also not a report publication announcement or certification. The document is a regulatory announcement about a financing-related business activity (foreign exchange derivatives) approved by the board. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is short (1441 characters), consistent with an announcement rather than a full report.
2021-11-16 Chinese
关于预计2022年度日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected related party transactions for the year 2022 by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the estimated amounts, counterparties, transaction types, pricing policies, and the necessity and impact of these transactions. It also includes information about the board meeting and shareholder approval process. The document is not a financial report, audit report, or earnings release, but rather a regulatory announcement about related party transactions and their approval status. This fits best under Regulatory Filings (RNS) as it is a compliance disclosure about related party transactions and corporate governance matters, not a full report or financial statement.
2021-11-16 Chinese
关于召开2021年第一次临时股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2021 first extraordinary general meeting of shareholders (临时股东大会) for Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes details about the meeting date, voting methods, agenda items, registration procedures, and contact information. The document does not contain financial statements or detailed financial analysis but serves as an official announcement for the shareholders' meeting. It is not a full report like an Annual Report or Interim Report, nor is it a voting result declaration. The document is relatively short (2648 characters) and is clearly a meeting notice. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or related to Annual or Extraordinary General Meetings, including notices of such meetings.
2021-11-16 Chinese
董事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new director to the company's board. It includes details about the nominee's qualifications, the board meeting resolution, and compliance with relevant laws and company bylaws. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of Board/Management Information, as it announces changes in the company's board of directors.
2021-11-16 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.